In our study, we found that higher Lp-PLA2 levels are associated with an increased risk of multiple or severe ICAS and that Lp-PLA2 levels were higher in AIS patients with ICAS than in those with one of the other three groups. The gene discussed is PLA2G7; the disease is androgen insensitivity syndrome.